0001599949-17-000001.txt : 20170303 0001599949-17-000001.hdr.sgml : 20170303 20170302190305 ACCESSION NUMBER: 0001599949-17-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170303 DATE AS OF CHANGE: 20170302 EFFECTIVENESS DATE: 20170303 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Orexigen Therapeutics, Inc. CENTRAL INDEX KEY: 0001382911 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 651178822 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-281701 FILM NUMBER: 17660857 BUSINESS ADDRESS: STREET 1: 3344 N. TORREY PINES CT. STREET 2: SUITE 200 CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: (858) 875-8600 MAIL ADDRESS: STREET 1: 3344 N. TORREY PINES CT. STREET 2: SUITE 200 CITY: LA JOLLA STATE: CA ZIP: 92037 D 1 primary_doc.xml X0707 D LIVE 0001382911 Orexigen Therapeutics, Inc. 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA CALIFORNIA 92037 (858) 875-8600 DELAWARE None None Corporation true Michael Narachi c/o Orexigen Therapeutics, Inc. 3344 N. Torrey Pines Ct. Ste 200 La Jolla CA CALIFORNIA 92037 Executive Officer Director Thomas Lynch c/o Orexigen Therapeutics, Inc. 3344 N. Torrey Pines Ct. Ste 200 La Jolla CA CALIFORNIA 92037 Executive Officer Thomas Cannell c/o Orexigen Therapeutics, Inc. 3344 N. Torrey Pines Ct. Ste 200 La Jolla CA CALIFORNIA 92037 Executive Officer Peter Flynn c/o Orexigen Therapeutics, Inc. 3344 N. Torrey Pines Ct. Ste 200 La Jolla CA CALIFORNIA 92037 Executive Officer Louis C Bock c/o Orexigen Therapeutics, Inc. 3344 N. Torrey Pines Ct. Ste 200 La Jolla CA CALIFORNIA 92037 Director Brian H. Dovey c/o Orexigen Therapeutics, Inc. 3344 N. Torrey Pines Ct. Ste 200 La Jolla CA CALIFORNIA 92037 Director David J Endicott c/o Orexigen Therapeutics, Inc. 3344 N. Torrey Pines Ct. Ste 200 La Jolla CA CALIFORNIA 92037 Director Peter K Honig c/o Orexigen Therapeutics, Inc. 3344 N. Torrey Pines Ct. Ste 200 La Jolla CA CALIFORNIA 92037 Director Patrick J Mahaffy c/o Orexigen Therapeutics, Inc. 3344 N. Torrey Pines Ct. Ste 200 La Jolla CA CALIFORNIA 92037 Director Lota S Zoth c/o Orexigen Therapeutics, Inc. 3344 N. Torrey Pines Ct. Ste 200 La Jolla CA CALIFORNIA 92037 Director Deborah Jorn c/o Orexigen Therapeutics, Inc. 3344 N. Torrey Pines Ct. Ste 200 La Jolla CA CALIFORNIA 92037 Director Jason Keyes c/o Orexigen Therapeutics, Inc. 3344 N. Torrey Pines Ct. Ste 200 La Jolla CA CALIFORNIA 92037 Executive Officer Pharmaceuticals Decline to Disclose 06b false 2017-02-23 false true true true false 0 49597000 49597000 0 Issuance of $49,597,000 in original principal amount of 2.75% Convertible Exchange Senior Notes due 2020 (the "New Notes") in exchange for $49,597,000 in original principal amount of 2.75% Convertible Senior Notes due 2020 (the "Existing Notes"). false 9 1552916 true 0 Represents a fee of $1,477,916 and $75,000 of expenses. 0 false Orexigen Therapeutics, Inc. /s/ Thomas Lynch Thomas Lynch EVP, General Counsel and Secretary 2017-03-02